Sector
HealthcareOpen
₹1,988Prev. Close
₹1,938.35Turnover(Lac.)
₹262.05Day's High
₹2,162.3Day's Low
₹1,98852 Week's High
₹2,35052 Week's Low
₹695Book Value
₹291.4Face Value
₹10Mkt Cap (₹ Cr.)
1,760.69P/E
40.81EPS
50.27Divi. Yield
0.15Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 8.57 | 8.57 | 7.49 | 7.49 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 219.21 | 187.53 | 16.44 | 15.16 |
Net Worth | 227.78 | 196.1 | 23.93 | 22.65 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 14.35 | 13.51 | 15.56 | 13 |
yoy growth (%) | 6.25 | -13.17 | 19.64 | -17.15 |
Raw materials | -11.26 | -10.14 | -10.49 | -7.51 |
As % of sales | 78.48 | 75.06 | 67.44 | 57.75 |
Employee costs | -1.63 | -1.52 | -1.52 | -1.71 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 2.08 | 0.61 | 0.56 | 0.27 |
Depreciation | -0.2 | -0.21 | -0.29 | -0.3 |
Tax paid | -0.36 | 0 | -0.04 | -0.04 |
Working capital | 0.35 | 0.84 | 2.41 | 1.06 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.25 | -13.17 | 19.64 | -17.15 |
Op profit growth | 405.3 | -121.86 | 3.28 | 2.83 |
EBIT growth | 143.89 | -22.74 | 19.9 | 18.26 |
Net profit growth | 179.89 | 18.04 | 126.17 | 23.03 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 74.12 | 61.84 | 80.65 | 226.74 | 28.87 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 74.12 | 61.84 | 80.65 | 226.74 | 28.87 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 12.53 | 7.23 | 6.9 | 2.89 | 1.6 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,139.15 | 140.98 | 1,10,740.42 | 231.3 | 0.13 | 686.11 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,242 | 92.73 | 1,04,128.85 | 369.6 | 0.22 | 2,135.4 | 569.62 |
Fortis Healthcare Ltd FORTIS | 683.2 | 272.19 | 51,578.74 | 39.63 | 0.15 | 357.15 | 120.23 |
Syngene International Ltd SYNGENE | 847.15 | 77.65 | 34,100.92 | 96.6 | 0.15 | 821.3 | 107.27 |
Global Health Ltd MEDANTA | 1,095.85 | 77.39 | 29,433.15 | 104.47 | 0 | 664.61 | 113.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
D K Dubey
Whole-time Director
N K Dubey
Independent Director
Shabbar Husain
Non Executive Director
Mithala Dubey
Company Sec. & Compli. Officer
Navneet Kaur
Independent Director
Abdul Moin Khan
Independent Director
Harihar Prasad Thapak
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by 3B Blackbio DX Ltd
Summary
3D Blackbio DX Ltd (Formerly known Kilpest India Ltd) was incorporated on May 25, 1972, as one of Indias leading Agri-based companies. Shri R.K. Dubey is the founder of this Company. It was the only pesticide formulating company in the entire region of Madhya Pradesh in 1970s. The company has now grown over the years and is leading today in Central India and manufactures about 50 pesticide products, microfertilizers, biofertilizers and biopesticides. The Company has representation in India in the field of agriculture business comprising crop protection, public health products and bio-products and is reputed reliable supplier to various Govt. organizations, such as Directorate General of Supplies & Transport, New Delhi, NAVY, Vishakapatnam/Mumbai, Food Corporation of India Raipur/ Bhopal/ Lucknow/ Mumbai/ Jaipur, NTPC, Bilaspur, Directorate of Health Service, M.P/Maharashtra/AP, Directorate of General Of Health Organization, Gujarat/U.P, Directorate General of Health services, MOH&FW (NVBDCP), Govt. of India, M/s Hindustan Latex Ltd, Noida, Director of Agriculture and Horticulture, M.P./Trivandrum, Central/Western Railway, Mumbai, Northern Railway, New Delhi etc. the company has nationwide distribution network of over 2000 dealers.It possess well equipped R&D laboratory duly approved and recognized by DSIR, Ministry of Science and Technology, Government of India. Advanced instrumentation facility supported by equally competent team of scientists and technicians lay down a str
Read More
The 3B Blackbio DX Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹2051.45 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of 3B Blackbio DX Ltd is ₹1760.69 Cr. as of 24 Dec ‘24
The PE and PB ratios of 3B Blackbio DX Ltd is 40.81 and 7.04 as of 24 Dec ‘24
The 52-week high/low is the highest and lowest price at which a 3B Blackbio DX Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of 3B Blackbio DX Ltd is ₹695 and ₹2350 as of 24 Dec ‘24
3B Blackbio DX Ltd's CAGR for 5 Years at 87.11%, 3 Years at 66.94%, 1 Year at 146.01%, 6 Month at 82.48%, 3 Month at 45.76% and 1 Month at 22.95%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice